Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Cognitive enhancers

Smart drugs worth £200,000 seized in the UK

A haul of “smart drugs” with a street value of £200,000 has been seized in the UK. The drugs, known as cognitive enhancers, are typically taken by students wishing to boost their performance. 

More than 20,000 items including 13 different types of drugs such as Noopept, phenylpiracetam, centrophenoxine, oxiracetam, sunifiram, citicoline and aniracetam, were discovered by the Medicines and Healthcare products Regulatory Agency (MHRA), it announced on 24 October 2014. 

The raid, which took place in Burton-Upon-Trent, came after an investigation by the MHRA following up on intelligence from the Norwegian Medicines Agency which had confiscated a number of packages traced back to an unlicensed online smart drug retailer. 

Alastair Jeffrey, head of enforcement at the MHRA, described the increasing popularity of smart drugs as a “worrying trend” and reiterated the dangers of taking smart drugs — a risk compounded by buying products online. 

Barbara Sahakian, a professor of clinical neuropsychology at the University of Cambridge, warned that there were no long-term studies into the side-effects of these drugs. 

“I am extremely concerned that young people are accessing these cognitive enhancing drugs via the internet, which is very unsafe as it is unclear what the drug sent actually contains,” she said. 

Under UK law, it is not illegal to possess cognitive enhancer drugs but it is an offence to sell or supply unlicensed or prescription-only medicines via an unlicensed retailer.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066977

Readers' comments (1)

  • This is establishment nonsense. I am a professional, 61 years old and a PhD student. I have been using these for years without any apparent side effects and you spew this kind of intelligence about something of which you state you don't really know the probable outcome? Get off your high horse, Barbara. Let me do what I want with my body, mind and spirit.

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.